European Journal of Chemistry

Spectrofluorimetric determination of Bisoprolol fumarate and Rosuvastatin calcium in a novel combined formulation and in human spiked plasma

Crossmark


Main Article Content

Nada Sayed Abdelwahab
Nouruddin Wageh Ali
Marco Mounir Zaki
Adel Ahmed Ali
Mohamed Mohamed Abdelkawy

Abstract

Sensitive, simple and rapid spectrofluorimetric method was developed for simultaneous determination of bisoprolol fumarate (BIS) and rosuvastatin calcium (ROS) in novel formulated tablets and in human spiked plasma depending on measuring their native fluorescence. The fluorescence intensity of BIS and ROS were measured in methanol at emission wavelength of 297 and 485 nm upon excitation at 227 and 242 nm, respectively. The emission spectrum of each drug reveals zero value at the emission wavelength of the other drug, thus allowing their simultaneous determination without any interference and without using any tedious derivatization steps. Excellent linearity was obtained over the range of 10-500 and 20-1000 ng/mL for BIS and ROS, respectively. The developed method was evaluated by applying to laboratory prepared mixtures and pharmaceutical formulation. The high sensitivity of the method was the motivation to its application for analysis of the cited drugs in spiked human plasma. Likewise, analytical and bioanalytical method validation was carried out following International Conference on Harmonisation guidelines and also statistical analysis with the reported methods was carried out and no significant difference was found. The developed method is the first developed spectrofluorimetric method for simultaneous determination of the newly formulated drugs.


icon graph This Abstract was viewed 2375 times | icon graph Article PDF downloaded 660 times

How to Cite
(1)
Abdelwahab, N. S.; Ali, N. W.; Zaki, M. M.; Ali, A. A.; Abdelkawy, M. M. Spectrofluorimetric Determination of Bisoprolol Fumarate and Rosuvastatin Calcium in a Novel Combined Formulation and in Human Spiked Plasma. Eur. J. Chem. 2018, 9, 331-337.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. The British Pharmacopoeia, Volumes II and III, Her Majesty's Stationery Office, London, UK. 2009.

[2]. Sweetman, S. C.; Martindale, The complete drug reference, 36th Edition, London; Chicago: Pharmaceutical Press, 2009.

[3]. United States Food and Drug Administration. Crestor (rosuvastatin calcium) Tablets. Prescribing Information Label. 2012; Available online: http://www. accessdata.fda.gov/drugsatfda_docs/label/ 2012/021366s026lbl.pdf (Accessed on 01 August 2018).

[4]. Bondjers, G.; Wiklund O.; Wikstrand J. Patent application number: US10/220, 790, Publication number: US20030060477-A1, Publication date: Mar 27, 2003. Available online: 3 July 2017 at https://www.google.com/patents/US20030060477?cl=en10 (Accessed on 01 August 2018)

[5]. Salem, H. J. Pharm. Biomed. Anal. 2002, 29, 527-538.
https://doi.org/10.1016/S0731-7085(02)00100-0

[6]. Tuljarani, G.; Sankar, D. G.; Kadgapathi, P.; Suthakaran, R.; Satyanarayana, B. Int. J. Chem. Sci. 2010, 8, 2253-2258.

[7]. Shirkhedkar, A. A.; Thorve, R. R.; Surana, S. J. Pakistan J. Pharm. Sci. 2008, 21, 366-369.

[8]. Abdelmonem, A. A.; Ragab, H. G.; Hashem, H.; Bahgat, E. A. UK J. Pharm. Biosci. 2016, 4, 43-52.
https://doi.org/10.20510/ukjpb/4/i2/97093

[9]. Goyal, R. N.; Tyagi, A.; Bachheti, N.; Bishnoi, S. Electrochim. Acta 2008, 53, 2802-2808.
https://doi.org/10.1016/j.electacta.2007.10.057

[10]. Kakde, R. B.; Kotak, V. H.; Kale, D. L. Asian J. Res. Chem. 2008, 1, 70-73.

[11]. Pradip, N. B.; Emanual, M. P.; Gautambhai. J. Chromatogr. Sep. Tech. 2013, 4, 1-4.

[12]. Savita, S. Y.; Janhavi, R. R. Int. J. Pharm. Pharma. Sci. 2013, 5, 286-290.

[13]. United States Pharmacopoeia, XXIV, United States Pharmacopoeia Convention, Washington, DC, 2007.

[14]. Shaikh, S.; Thusleem, O. A.; Muneera, M. S.; Akmal, J.; Kondaguli, A. V.; Ruckmani, K. A. J. Pharm. Biomed. Anal. 2008, 48, 1055-1057.
https://doi.org/10.1016/j.jpba.2008.08.009

[15]. Hefnawy, M. M.; Sultan, M. A.; Al-Shehri, M. M. J. Liq. Chromatogr. Relat. Technol. 2006, 29, 2901-2914.
https://doi.org/10.1080/10826070600978302

[16]. Athota, R. V.; Jagarlapudi, S. K.; Singampalli, M. R. Int. J. Pharm. Tech. Res. 2016, 9, 329-339.

[17]. Erdal, D.; Zehra, C. E.; Ghazal, R. J. Liq. Chromatogr. Relat. Technol. 2015, 38, 970-976.
https://doi.org/10.1080/10826076.2014.999200

[18]. Sevinc, K.; Paula, R. S. M.; Bengi, U.; Sibel, A. O. Chromatographia 2014, 77, 365-371.
https://doi.org/10.1007/s10337-013-2606-4

[19]. Tutunji, M. F.; Ibrahim, H. M.; Khabbas, M. H.; Tutunji, L. F. J. Chromatogr. B 2009, 877, 1689-1697.
https://doi.org/10.1016/j.jchromb.2009.04.021

[20]. Arjun, S.; Sivakumar, T.; Jain, D. A.; Umesh, M.; Arun, K. Y.; Tarun, S. Int. J. Pharm. Res. Dev. 2011, 3, 1-3.

[21]. Baldut, M.; Bonafede, S. L.; Petrone, L.; Simionato, L. D.; Segall, A. I. Adv. Res. 2015, 5, 1-8.
https://doi.org/10.9734/AIR/2015/19843

[22]. Rekha, R.; Anbazhagan, S.; Kumar, P. R. Int. J. Pharm. Tech. Res. 2012, 4, 1601-1605.

[23]. Jain, P. S.; Kale, N. K.; Surana, S. J. J. Pharm. Biosci. 2013, 4, 128-133.

[24]. Gupta, A.; Mishra, P.; Shah, K. E-J. Chem. 2009, 6, 89-92.
https://doi.org/10.1155/2009/956712

[25]. Garg, S. Acta Velit. 2014, 1, 20-24.

[26]. Alzoman, N. Z.; Sultan, M. A.; Maher, H. M.; Alshehri, M. M.; Wani, T. A.; Darwish, I. A. Molecules 2013, 18, 7711-7725.
https://doi.org/10.3390/molecules18077711

[27]. Ramadan, A. A.; Mandil, H.; Alshelhawi, N. Int. J. Pharm. Pharma. Sci. 2014, 6, 579-585.

[28]. Krishna, M. V.; Sankar, D. G. E-J. Chem. 2007, 4, 46-49.
https://doi.org/10.1155/2007/454853

[29]. Braga, V. S. M.; Mancilha, T. P.; Cassella, R. J.; Pacheco, W. F. J. Fluoresc. 2013, 23, 49-55.
https://doi.org/10.1007/s10895-012-1115-4

[30]. Nadia, M. M.; Amr, M. B.; Nesrine, T. L.; Abd El-Aleem, A. B. J. Liq. Chromatogr. Relat. Technol. 2014, 37, 2182-2196.
https://doi.org/10.1080/10826076.2013.828305

[31]. Sane, R.; Kamat, S.; Menon, S.; Inamdar, S.; Mote, M. J. Planar Chromatogr. Mod. TLC 2005, 18, 194-198.
https://doi.org/10.1556/JPC.18.2005.3.4

[32]. Ramadan, A. A.; Hussen, A.; Maktabi, M. Int. J. Pharm. Pharm. Sci. 2014, 6, 180-188.

[33]. Devi, S. U.; Latha, E. P.; Guptha, C. V. N. K.; Ramalingam, P. Int. J. Pharma. Bio. Sci. 2011, 2, 134-140.

[34]. Shekhar, M. C.; Babu, G. R.; Dinda, S. C.; Sonthosh, P. V.; Shwetha, P. Int. J. Pharm. 2014, 4, 335-339.

[35]. Palvai, S.; Seelam, S. C.; Dhanalakshmi, K.; Reddy, N. Int. J. Pharm. Technol. 2013, 4, 182-187.

[36]. Caglar, S .; Toker, S. J. Chrom. Sci. 2013, 51, 53-58.
https://doi.org/10.1093/chromsci/bms105

[37]. Turabi, Z. M.; O'hood, A. K. ‎Int. J. Pharm. Sci. Drug Res. 2014, 6, 154-159.

[38]. Banker, G.; Anderson, N. R. Tablets (Chap. 11). In: The Theory and practice of industrial pharmacy, 3rd Ed. , Lachman, L.; Lieberman, H. A.; Kanig, J. L. (Eds), Lea and Febiger, Philadelphia, P. A. 1986, pp. 294.

[39]. Fiese, E. F.; Hagen, T. A. Preformulation (Chap. 8). In: The Theory and practice of industrial pharmacy, 3rd Ed. , Lachman, L.; Lieberman, H. A.; Kanig, J. L. (Eds), Lea and Febiger, Philadelphia, P. A. 1986, pp. 171.

[40]. Bakan, J. A. Capsules (Chap. 13), Part three microencapsulation. In: The Theory and practice of industrial pharmacy, 3rd Ed. , Lachman, L.; Lieberman, H. A.; Kanig, J. L. (Eds), Lea and Febiger, Philadelphia, P. A. 1986, pp. 412.

[41]. International Conference on Harmonization Q2 (R1), Validation of analytical procedures: Text and methodology, ICH Harmonized Tripartite Guideline, 2005.

Supporting Agencies

Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).